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Background: Incorrect use of inhaler devices remains an obstacle for respiratory diseases man-
agement. We aimed to evaluate the frequency of inhaler technique errors; to determine the
devices perceived as the easiest and favourite to use; to study the association of device type,
demographics and patient preferences with inhaler technique (IT).
Methods: Cross-sectional assessment of 301 adults, with asthma (194) or chronic pulmonary
obstructive disease, undergoing treatment with Aerolizer, Autohaler, Breezehaler, Dis-
kus, Handihaler, MDI without spacer, Miat-haler, Novolizer, Respimat and/or
Turbohaler. Patients completed self-assessment questionnaires and face-to-face interview,
with demonstration of inhaler technique. The rate of wrong steps (number of wrong
steps O number of total steps; RWS) was the primary outcome. Adjusted odds ratio (aOR)
(95% confidence intervals [CI]) for presenting 1 IT errors were computed.
Results: From the 464 inhaler technique performances, the median RWS was 18%. Turbohaler
(21%) and Diskus (19%) were chosen as easiest and Novolizer (18%), Diskus (18%),
Turbohaler (17%) as favourite for daily use. Females (aOR 2.68 [95% CI 1.55e4.65]; vs. males],
patients with >64 yr (aOR 2.73 [95% CI 1.15e6.48]; vs <45 yr) and patients using Aerolizer or
Handihaler (aOR 3.24 [95% CI 1.13e9.32] and aOR 3.71 [95% CI 1.38e10.2], respectively) were
more likely to perform IT errors; otherwise, no association was found, including with using the
favourite device (aOR 1.43 [95% CI 0.84e2.42]).e Medicina da Universidade do Porto, Alameda Professor Hernaˆni Monteiro, 4200-319 Porto, Portugal.
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Inhaler devices in asthma and COPD 969Conclusion: The frequency of inhaler technique errors was high and no device was clearly
preferred over the others. Using the preferred inhaler device was not associated with less er-
rors.
ª 2014 Elsevier Ltd. All rights reserved.Introduction
Inhaled therapy is the cornerstone in the management of
asthma and chronic obstructive pulmonary disease (COPD).
There are two main groups of inhaler devices: metered
dose inhalers (MDI) and dry powder inhalers (DPI). Many
devices have been developed and each has specificities on
how to prepare the dose and deliver the drug to the air-
ways. Although different devices have technological im-
provements to airway drug delivery, important limitations
remain [1]. In fact, decades after the introduction of
inhaler devices, their incorrect use remains an obstacle to
achieve optimal disease outcomes [2].
The correct use of inhaler devices is one of the most
important aspects to be taken into account when evalu-
ating individuals with asthma or COPD, and guidelines [3,4]
emphasize the importance of assessing inhaler technique to
improve the efficiency of drug delivery. Furthermore, it is
recognized that inadequate use of inhaler devices is one of
the most common reasons for failure to achieve asthma
control [3]. A recent review reports a high percentage of
inhaler technique errors, but with great variability among
studies [5]. Moreover, the perceived complexity of inhaled
therapy may lead to treatment withdrawal, further
impairing the achievement of disease control. In fact,
Santus et al. [6] found that 18% of patients stopped inhaled
therapy spontaneously, mainly due to the complexity of
treatment, despite a reported suitable medical
explanation.
To understand how to improve the use of inhalers,
different aspects have been studied, such as types of de-
vices [2,7e10]; patient factors (age, gender, education)
[2,9,11,12]; and patient preferences. [8,13] Yet, research
results regarding the interaction between patient, device
and technique are insufficient and inconsistent.
The aims of this study are: 1) to evaluate the frequency
of errors in the inhaler technique of asthma and COPD pa-
tients; 2) to determine which inhaler device is perceived as
the easiest and which is considered the favourite for daily
use; 3) to study the association of device type, de-
mographic characteristics and patient preference variables
with inhaler technique.Material and methods
Study design and participants
This was a cross-sectional observational study, carried out
in the Allergology and Pneumology outpatient clinics of the
Centro Hospitalar Sa˜o Joa˜o, a tertiary university hospital in
Porto, Portugal, from April to August 2013. Adult patients
attending the outpatient clinics were invited to participateand were included if they had a medical diagnosis of
asthma or COPD and were currently using an inhaler device.
In this study, we assessed the most commonly used devices
from those available in Portugal: Aerolizer, Autohaler,
Breezehaler, Diskus, Handihaler, MDI without spacer,
Miat-haler, Novolizer, Respimat and Turbohaler. Pa-
tients using different inhaler devices or those who were
unable to read and/or write were excluded.
This study was conducted according to the principles of
the Helsinki Declaration. Written informed consent was
obtained from all participants. The study procedures were
approved by the Ethics Committee of Centro Hospitalar Sa˜o
Joa˜o. We have followed STROBE recommendations for
reporting observational studies [14].
Instruments and data collection
Data were collected using a structured written question-
naire (filled autonomously by the patient) and a face-to-
face interview.
First, the participant answered a questionnaire which
evaluated the self-perception on his/her inhaler technique
(“I perform correctly the technique of my inhaler”), satis-
faction with the inhaler device, including comfort with
public use (“I feel satisfied with my inhaler” and “I feel
comfortable using my inhaler in public”) and the perception
on how his/her preferences were taken into account at the
time of inhaler’s prescription (“I feel that my physician
took into account my opinion and preferences when
choosing my inhaler”). These questions were answered
using Visual Analogic Scales (VAS), ranging from 0 (worst) to
100 (best) millimetres.
Immediately after, without any additional training, each
participant was asked to show the interviewer how he/she
usually used the inhalers currently prescribed, using pla-
cebo devices. The inhaler technique for each device was
evaluated through observation using checklists based on
the manufacturers’ instructions available in the Portuguese
drug agency database [15]. Summarized lists of the rec-
ommended inhaler steps for each device are presented in
Supplementary Tables 1e3. The interviewer registered if
each step was performed properly and in an adequate
order.
After the assessment of inhaler technique, the inter-
viewer explained the adequate inhaler technique for the
participant’s device(s) and demonstrated how to use the
remainder inhalers. After the explanation and demonstra-
tion of use, each participant had the opportunity to test the
available inhalers by him/herself.
Finally, each participant was asked to elect the device
perceived as the easiest and the one they would prefer for
daily use; the reason(s) underlying the choice of the inhaler
for daily use were inquired through an open question.
970 P. Chora˜o et al.The study questionnaire was pre-tested in 12 patients in
order to check for readability and ease of understanding.
To ensure uniformity of the assessment, all interviews were
performed by the same trained interviewer. In order to
reduce possible confounding related to differences in the
therapeutic effect of inhaled drugs available for each de-
vice, it was explicitly stated, during the interview, that all
questions were related only to the physical and functional
aspects of the inhalers and not to the drug and/or its ef-
fects or safety.Table 1 Participants diagnosis, demographics and number
of different inhalers used (n Z 301).
All
301
n %
Diagnosis
Asthma 194 64
COPD 107 36
Gender (females) 181 60
Age (mean, SD) 53 17
<45 90 30
45e64 132 44
>64 79 26
School years
1e4 138 46
5e9 67 22
10e12 62 21
>12 34 11
Number of current different inhalers
1 166 55
2 108 36
3 27 9Statistical analysis
The main outcome of this study was the rate of wrong steps
(RWS), defined as number of inhaler technique wrong steps
divided by the total number of recommended steps. We
calculated the sample size based on the RWS. Considering a
significance level of 0.05, we admitted a standard deviation
for the RWS of 0.15, with a margin of error of 0.014. The
sample size calculated for these parameters was 444
demonstrations of inhaler technique. Considering the same
standard deviation of 0.15 for the RWS of each inhaler de-
vice, the inclusion of 40 demonstrations per device gives
this study a power of 85% to detect a difference of 0.1
between the RWS of two different inhalers.
Categorical variables were described using absolute
frequencies and proportions with 95% confidence intervals
(95% CI); comparisons were performed using the Pearson
chi-square test. For statistical analysis, age was recoded in
three groups (<45; 45 to 64; and >64 years old) and the
level of education was categorized according to the Por-
tuguese education system (1e4; 5e9; 10e12; and >12 years
of school education). Continuous variables were described
using mean with standard deviation (SD) or median with
interquartile range, as appropriate to the data distribution;
comparisons were performed using non-parametric Man-
neWhitney U and KruskalleWallis tests, as adequate. The
inhalers used by less than 5% of total patients were not
analysed individually except in what refers to the patient’s
preferences. The associations between the RWS and both
VAS score and duration of inhaler use were studied with
Spearman correlation coefficients (r2). The level of signifi-
cance was set at p < 0.05.
Univariate logistic regression models were developed
using independent variables as risk factors for “presence of
errors in the inhaler technique”. The univariate models
considered all the available factors with a possible associ-
ation with the inhaler technique, including patient char-
acteristics (medical diagnosis, gender, age and school
education), device features (type of device, time of use
and number of different devices in use) and patient pref-
erences regarding the devices that are considered the
easiest and the favourite for daily use. Multivariate logistic
regression models were developed for the presence of er-
rors in the inhaler technique. The factors with a p-value
<0.250 in the univariate analysis were included in the
initial multivariate model; the model was progressively
adjusted considering its calibration (HosmereLemeshow
statistics), discriminative power (Area Under the Curve
from the Receiver Operating Curve) and the adjusted p-
value of each variable; a p > 0.05 in theHosmereLemeshow statistics was deemed necessary to
consider that the model was calibrated. The final model
included gender, age groups, years of school education and
type of inhaler device; interactions (2  2) between
different variables were tested but did not significantly
improve the model and were not included. Results of both
univariate and multivariate logistic regression models were
presented as odds ratio (OR) with [95% confidence interval
(95% CI)]. Statistical analysis was conducted using SPSS
Statistics version 21 for Windows (IBM SPSS, Chicago, IL,
USA).Results
Overall, 464 devices were being used by the 301 individuals
included in the study. All the participants completed the
study questionnaire and there was no missing data
regarding individual questions.
The characteristics of the participants and their
currently used inhalers are presented in Tables 1 and 2,
respectively. Turbohaler and Diskus were the most
widely used devices, accounting for 27% and 19%, respec-
tively, of all inhalers; Autohaler, Breezehaler, Miat-
haler, Novolizer and Respimat represented less than 5%
of the devices in current use. Individuals with asthma used
more frequently Turbohaler (corresponding to 34% of total
inhalers used in asthma), while most patients with COPD
reported to use Handihaler and Diskus (26% and 21% of
total COPD devices, respectively). Duration of use was, on
average, similar between devices (mean [SD] 4e5 (4e5)
years) except for MDI, which had been in use for a longer
period [9 (10) years]. High grades were reported in the
self-evaluation of inhaler technique (median 94%, p25ep75
74e94%) and satisfaction with the current device (median
87%, p25ep75 74e94%). Table 2 summarizes these results to
Table 2 Devices used, perception of correct technique and satisfaction with current inhaler (n Z 464).
Devices
(n Z 464)
Frequency of use Self-evaluation of correct
techniquea
Satisfaction with current
devicea
n % P50 (P25eP75) P50 (P25eP75)
Turbohaler 128 27 86 (74e97) 79 (74e97)
Diskus 90 19 95 (74e97) 90 (74e97)
Handihaler 77 17 96 (75e97) 93 (74e97)
Aerolizer 64 14 96 (75e97) 93 (75e97)
MDI 54 12 92 (74e97) 92 (74e97)
Respimat 18 4 97 (76e97) 95 (74e98)
Novolizer 12 3 78 (74e97) 74 (50e94)
Breezehaler 11 2 96 (85e98) 96 (78e97)
Miat-haler 8 2 59 (12e97) 62 (8e75)
Autohaler 2 <1 62 (49e74) 50 (49e50)
a Visual analogic scale, range 0e100 (best).
Figure 1 Percentage of participants with flawless inhaler
technique performances (diamonds) and distribution of rate of
wrong steps (boxes and whiskers). Footnote: Percentage of
users with flawless inhaler technique performances is repre-
sented by the diamond symbol. Distribution of the rate of
wrong steps (number of wrong steps O total number of steps;
RWS) for the more frequently used devices. Box represents
25e75 percentiles and rectangle box the median. Whiskers
represent 5 and 95 percentiles. Pearson chi-square test was
used to test for statistical significant differences in the per-
centage of flawless inhaler technique executions and Man-
neWhittney U test was performed to test for statistically
significant differences in the RWS. * p Z 0.006 for Turbohaler
vs Handihaler. U p Z 0.011 for Turbohaler vs Aerolizer. y
p Z 0.001 for Turbohaler vs Handihaler. z p Z 0.020 for Tur-
bohaler vs Aerolizer. # p Z 0.015 for Turbohaler vs MDI. x
p Z 0.038 for Diskus vs Handihaler.
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involvement in the choice of the device(s) and public use of
the inhalers were also high (median 75%, p25ep75 26e96%
and median 86%, p25ep75 48e97%, respectively).
Fig. 1 shows the percentage of flawless inhaler tech-
nique performances and the distribution of the RWS for the
most widely used inhaler devices. The frequency of errors
at each recommended step, discriminated by device, is
presented in the Supplementary Tables 1e3 available
online.
When considering the preference on the easiest inhaler
device, 56% of patients chose their current inhaler, 10%
chose devices used in the past and 34% elected an inhaler
they had never used. When considering the favourite device
for daily use, 40% of participants chose their current de-
vice, 9% a device used in the past and most (51%) preferred
a device they had never used. Fig. 2 shows the proportion of
patients reporting each device as the preferred (consid-
ering both the easiest and the favourite for daily use).
Table 3 describes the reasons underlying the choice of an
inhaler for daily use. Physical characteristics of the device
were the most frequently reported motives for choosing an
inhaler as the favourite (Table 3); characteristics such as
the colour control window present in Novolizer (which
provides feedback to the patient) and the compact format
of Breezehaler were referred, respectively, by 70% and
48% of the participants who selected Novolizer and
Breezehaler, as the most important reasons for their
choices.
Duration of use (p Z 0.253), perception of correct
technique performance (p Z 0.106), satisfaction with the
device (p Z 0.376), patient involvement by the physician
(p Z 0.947) and comfort with the use of the device in
public (p Z 0.607) did not significantly correlate with the
RWS.
Females (vs. males, p < 0.001), older individuals (>64
vs. 64 years old; p < 0.001) and those with lower level of
education (1e4 years vs. >12 years; p Z 0.001) had a
higher RWS. The diagnosis of asthma or COPD (p Z 0.643),
the number of different inhalers used (p Z 0.067),
currently using the device chosen as the easiest to use
(p Z 0.292) and currently using the favourite device(p Z 0.092) had no statistically significant association with
the RWS.
Table 4 presents the odds ratio with 95% CI for inhaler
technique with errors, based on the univariate and multi-
variate logistic regression analysis. Individuals who where
not using their favourite device had no significant increase
Figure 2 Percentage of patients reporting each device as the
preferred, considering the easiest (left panel) and the
favourite for daily use (right panel) devices, n Z 301 patient.
972 P. Chora˜o et al.in the OR for the presence of at least one error in the
inhalation technique (crude OR 1.43 [95% CI 0.84e2.42]; vs.
already using the favourite device).
Discussion
In this cross-sectional observational study we observed a
high RWS in inhaler technique and a corresponding low
percentage of inhaler technique performances without er-
rors. In multivariate analysis, females, elder patients and
those using the Aerolizer and Handihaler devices had
higher odds of performing errors. Other variables such as
inhaler device factors (e.g.: using more than one type of
device), medical diagnosis, education and patient prefer-
ences, including using the preferred inhaler device, were
not associated with correct inhaler technique. Finally,
there was no consensus on the inhaler device to be
considered as the ‘easiest’ or as the ‘preferred for daily
use’.
Our study design takes a pragmatic approach to inhaler
technique assessment in asthma and COPD patients that is
applicable to routine clinical care. Inhaler technique was
assessed through observation of patient’s demonstration by
face-to-face interview, and we used checklists based on the
manufactures’ instructions. As participants inclusion
criteria were broad and based on the medical diagnosis of
asthma or COPD, they had a fairly diverse experience with
inhaled therapy. Furthermore, we comprehensivelyassessed factors that have previously been described
separately, such as the type of inhaler device, disease,
demographic characteristics and patient preferences. We
included a set of 10 different inhaler devices, which is, to
our knowledge, the largest to be simultaneously assessed in
a study. Patient preferences have not been previously
studied in such a comprehensive scenario.
Nevertheless, this study has some limitations that should
be considered. We could not compare all devices regarding
the RWS, because some devices (Autohaler, Breezehaler,
Miat-haler, Novolizer, Respimat) were used infre-
quently. During the interviews we felt patients often had
difficulties in separating previous experiences with medi-
cations from the devices that were used to deliver them,
although it was explicitly said by the interviewer that only
the physical and functional aspects of the device were
being evaluated. Also, some participants might have not
fully understood the VAS questions. Moreover, under or over
reporting of inhaler technique errors due to interviewer
bias can not be excluded, although using a single inter-
viewer prevented inter-observer variability. We recognise
that evaluating some steps, especially the rapid and
forceful inhalation needed to correctly use a DPI, only
through observation is subjective, but it simulates a real
life setting, where most decisions are clinically based and
the equipment to accurately measure the inspiratory flow is
seldom available. Also, we did not questioned the patients
about the type of training on inhalation technique they had
previously or about how long ago they had that training and
who ministered it. Thus, we cannot assess the influence of
past training in the performances observed. Likewise, the
cross-sectional design limits the interpretation of the
findings and influence of duration of use on the frequency
and dynamics of technique errors. Additionally, this study
was conducted in a single healthcare institution and we
cannot exclude a selection bias; furthermore, illiterate
individuals were excluded. This may limit the generaliza-
tion of our results to other populations.
A critical limitation to all studies evaluating inhaler
technique is the lack of consensus regarding the method-
ology to assess and value errors. Other studies used several
different methods such as critical errors [2], essential steps
[7,9,10], grading systems [8] or error cut-offs [11e13,16].
We calculated a rate of wrong steps, without valuing any
particular steps. This method may overestimate the prev-
alence of incorrect use of inhaler devices, since it considers
all steps recommended by manufacturers as a potential
source of error, but it reduces the subjectivity of grading
the relevance of some errors over others in the absence of
solid knowledge on the importance of each error on the
distribution of the drug into the airways.
Inhaler technique assessment detected a high RWS
across many of inhaler technique stages, which corre-
sponded to low proportion of performances without mis-
takes. In previous studies, Turbohaler was reported as
having more technique errors than MDI, Handihaler, Aer-
olizer and Diskus [2,17] but surprisingly we observed that
Turbohaler surpassed the performance of MDI and the
single-dose DPI devices, while Diskus was only statistically
different from Handihaler. Despite this result, no inhaler
device had an overall technique performance that was su-
perior to all the others.
Table 3 Motives stated by participants for choosing a device as favourite for daily use, sorted by preference for daily use (see
Fig. 2).
Accustomed to
18%
Easy
26%
Practical
26%
Physic
characterist.
30%
n % n % n % n %
Novolizer 1 1 5 8 6 9 54 82
Diskus 14 21 19 29 25 38 8 12
Turbohaler 27 44 9 14 15 24 11 18
MDI 9 21 18 41 14 31 3 7
Autohaler 1 4 18 67 6 22 2 7
Breezehaler 2 7 6 21 5 17 16 55
Aerolizer 5 23 9 41 6 27 2 9
Handihaler 5 26 4 21 7 37 3 16
Respimat 2 10 4 21 7 37 6 32
Miat-haler 2 100
The reasons stated by the participants were grouped according to its general type: ‘Practical’ includes ‘practical’ and ‘fast to use’;
‘Physic characterist.’ includes ‘colour control window’ (only for Novolizer), ‘small size’, ‘hygienic’, ‘dosage counter’, ‘design’ and
‘discretion’.
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worsens the clinical outcome [2,16,18], and therefore our
data is motive of concern. Despite the differences in the
inhalation technique, the choice of the inhaler device
should be based on a physician-patient agreement,
considering patient preferences, skills, availability of the
intended drug, cost and physician experience [1,3,4]. An
educational project on inhaler technique directed both to
healthcare professionals and patients reported improved
outcomes in asthma and COPD patients [19], underlining
the role the effectiveness of educational interventions.
Other interventions suggest that education should be pro-
vided in a continuous [13] and interactive fashion [18].
Furthermore, evidence suggests that if the inhaler tech-
nique is performed correctly, similar outcomes can be
achieved regardless of the type of inhaler device used by
the patient [20].
All inhaler devices included in this study had similar
average durations of use, with the exception of MDI that
had been used for a longer period of time. It has been
suggested that the duration of inhaler use may be associ-
ated with the presence of errors in inhaler technique.
However, in accordance with the results reported by
Hashmi et al., [11] we did not observe such relationship.
Likewise, our results are in agreement with previous liter-
ature reporting that there is no difference in the perfor-
mance of inhaler technique according to the number of
inhaler devices in use [2,9]. However, some authors re-
ported more misuse amongst patients with multiple types
of devices [7,10,12].
A previous study by Melani et al. [2] reported no statis-
tically significant differences in inhaler technique between
asthma and COPD patients, after adjusting for inhaler de-
vice, age and level of instruction. Our data support this lack
of association. Nevertheless, they are discrepant with the
results from Khassawneh et al.; [7] in that study there is a
report of higher odds of incorrect inhaler technique in
COPD patients, after adjusting for age, gender and level of
education, although the authors attribute the difference toolder age and the presence of more comorbidities in COPD
patients.
When considering demographic variables, we observed a
higher odds ratio of poor inhaler technique in the elderly,
as observed in previous studies [2,9]. Moreover, our data
suggests that females, when compared to males, present a
greater odds of having incorrect inhaler technique. How-
ever, in what refers to gender, most of the published
studies reported no differences in inhaler technique
[2,9,11,12]. This disagreement may be due to methodo-
logical differences, such as restricted analysis to specific
errors [2,9] or application of cut-offs to define correct
technique [11,12]. Nevertheless, it seems that female pa-
tients often have worse asthma control in spite of higher
inhaled corticosteroid use [21] and COPD females seem to
have more limitation, more dyspnoea and higher con-
sumption of respiratory medication [22]. Furthermore,
anxiety and depression are known to affect symptoms.
Women with asthma have higher anxiety levels and female
asthma patients with anxiety consume more asthma medi-
cation [23], and, in COPD, anxiety and depression are
related to dyspnoea, although equally prevalent in males
and females [24]. Still, inhaler technique may contribute to
the different outcomes observed between genders and
should be addressed in future studies.
An inverse relation between years of school education
and incorrect inhaler technique was previously reported
[2,11]. We observed a similar trend in multivariate logistic
regression analysis, with individuals with 5e9 years of
school education presenting the highest OR for incorrect
technique; however, individuals with higher level of school
education were not significantly different from those with
1e4 years of education. Fayas et al. [12] observed that
knowledge on asthma and inhaler technique, but not the
level of academic education, was associated with better
inhalation techniques; in our study, no specific data on
asthma knowledge was collected. Nevertheless, recently,
the WHO Regional Office for Europe suggested school edu-
cation as one of the many factors that influences health
Table 4 Odds ratio (OR) from univariate (crude) and
multivariate (adjusted) logistic regression analysis for the
presence of at least one error in the inhaler technique.
Crude OR (95% CI) Adjusted OR (95% CI)
Diagnosis
Asthma 1.02 (0.62e1.66)
COPD Reference NI
Gender
Male Reference Reference
Female 2.01 (1.23e3.29) 2.68 (1.55e4.65)
Age groups (years)
<45 Reference Reference
45e64 2.18 (1.23e3.86) 2.29 (1.11e4.75)
>64 2.13 (1.12e4.06) 2.73 (1.15e6.48)
School years
1e4 Reference Reference
5e9 1.80 (0.86e3.76) 3.11 (1.31e7.37)
10e12 0.75 (0.40e1.40) 1.27 (0.57e2.86)
>12 0.58 (0.28e1.21) 0.87 (0.36e2.09)
Number of different devices
1 Reference NI
>1 1.80 (1.10e2.94)
Inhaler device
Aerolizer 3.46 (1.27e9.42) 3.24 (1.13e9.32)
Diskus 1.36 (0.69e2.68) 1.51 (0.73e3.11)
Handihaler 3.47 (1.37e8.79) 3.71 (1.38e10.02)
MDI 1.47 (0.64e3.35) 1.07 (0.45e2.57)
Other 0.86 (0.40e1.82) 0.97 (0.43e2.18)
Turbohaler Reference Reference
Time of inhaler use (years)
<1 Reference NI
1 to 5 1.36 (0.73e2.53)
>5 1.28 (0.65e2.53)
Already using the easiest device
Yes Reference NI
No 1.26 (0.77e2.08)
Already using the favourite device
Yes Reference NI
No 1.43 (0.84e2.42)
NI e Not included.
974 P. Chora˜o et al.literacy [25]; this WHO manuscript did not include data
from Portugal. Still, our observation seems to imply that
physicians should not fully rely on the level of education as
a predictor of correctness of inhalation technique.
Guidelines recommend considering patient’s opinions
and preferences regarding their inhaler device(s) and
technique(s) when assessing inhalation technique [3]. Press
et al. [18] reported that patients over-estimate their
inhaler technique. Our analysis supports these findings,
since most patients were confident about the correctness of
their inhaler technique performance and this self-
perception was not significantly associated with a lower
RWS. Additionally, we observed that higher satisfaction
with the inhaler device, personal perspective of being
engaged by the physician in the choice of the device and
feeling comfortable to use inhaler devices in public had no
significant influence on the performance of inhaler
technique.To study patient preferences, we compared ten inhaler
devices to determine which was considered the easiest and
the preferred for routine use but we could not identify an
inhaler clearly favoured over the others. Interestingly,
however, preferences seem to be greatly influenced by the
prescription experience of our patients, since 66% chose
the easiest device and 49% the preferred for routine use
among those currently or formerly used.
When considering the motive(s) for choosing an inhaler
device as the preferred for routine use, we observed that
reasons and their relative representation varied across each
device. This opposes a previous report on patient prefer-
ences that referred that ease of use was the leading reason
underlying the patient’s choice; nevertheless that study
was not designed to assess motives [8]. The widely
distributed preferences relating inhaler devices along with
the existence of diverging reasons for the choice, indicates
that prescription should not be standardized and that each
patient must be considered individually.
Lenney et al. [8] previously reported that prescribing the
preferred device to the patient might improve inhaler
technique. In that study, the authors recruited patients
referred for inhaler assessment and evaluated inhaler
technique for all the devices immediately after giving
verbal instruction and demonstrating their use. In our
study, data does not support an association between using
the preferred inhaler device and the correctness of inhaler
technique. However, we invited participants with different
backgrounds of inhaler use from an outpatient clinic and
inhaler technique was assessed prior to any demonstration
from the interviewer, which represents a more reliable
approach to a real-life clinical setting.
In conclusion, incorrect inhaler technique is frequent,
especially in older patients, female patients and those
using single-dose DPIs. No inhaler device had a significant
lower rate of wrong steps or was clearly preferred by the
majority of the patients. Our data suggests that prescribing
the patient’s preferred inhaler is not associated with a
better inhalation technique.
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